Organizing Committee
- Murat Akova, Ankara, TR
- Giuseppe Cornaglia, Verona, IT
- Cornelia Lass-Flörl, Innsbruck, AT
Conference Objectives
Participants attending this conference will learn about the microbiological aspects, pathophysiology and clinical presentations of common and emerging invasive fungal infections. Up-to-date information on diagnosis and treatment for these infections will also be discussed in detail and future prospects will be highlighted.
Conference Venue
Auditorium, Policlinico Universitario A. Gemelli
Università Cattolica Sacro Cuore
Largo Francesco Vito, 1
Rome, IT.
Target Audience
Specialists or physicians in training in the following disciplines: infectious diseases, clinical microbiology, mycology, other disciplines dealing with immunocompromised patients (e.g. haematology, oncology, chest medicine).
Application Procedure
Please complete the registration form (see right column).
Tuition Fee
Members of ESCMID and Affiliated Societies:
- Before and on 18 November 2009: EUR 500
- After 18 November 2009: EUR 650
All others:
- Before and on 18 November 2009: EUR 700
- After 18 November 2009: EUR 800
The tuition fee includes the scientific sessions, printed conference material, lunches and coffee breaks, but not travel and accommodation costs.
Attendance Grants
ESCMID provides a number of attendance grants for young attendees (born in 1970 or later) covering the tuition fee, but no travel or accommodation costs. Please submit your application until 8 January 2010 online on this website (see right column). Please include a short CV with a cover letter indicating your motivation for attending the event and your ESCMID or affiliated society membership number (if applicable). If there are more applicants than available grants, preference will be given to ESCMID members. Applicants will be informed about their acceptance by 22 January 2010.
Scientific Secretariat
Giuseppe Cornaglia
Department of Pathology
University of Verona
Phone +39 045 802 71 96
Fax +39 045 584 606
giuseppe.cornaglia[at]univr.it
Conference Secretariat
ICO
Marco Moschin
Via Lorenzo Marcello 32
30126 Lido di Venezia (VE)
Italy
Phone +39 041 52 62 530
Fax +39 041 52 71 129
ico[at]icorganization.it
Final Conference Programme
Thursday, 18 February 2010
1. Trends of fungal epidemiology in Europe
9.00 Global trends in Candida species distribution. Elisabeth M. Johnson
9.20 Global trends in Aspergillus species and other rare moulds. Paul Verweij
9.40 Zygomycosis survey in Europe. George Petrikkos
10.00 Imported mycosis. Marcio Nucci
10.20 Discussion
10.40 Coffee break
2. Current limitations in diagnosing invasive fungal infections: laboratory and imaging options
11.00 The classical diagnostic assays for fungal infections. Sevtap Arikan
11.20 Update on molecular diagnostic tests for yeast and mould infections. Stéphane Bretagne
11.40 Imaging for pulmonary and extra-pulmonary fungal infections. Claus Peter Heussel
12.00 What is the role for in vitro-susceptibility testing for the daily routine? Cornelia Lass-Flörl
12.20 Discussion
12.40 Lunch
3. New insights into antifungal resistance
13.40 The issue of candine antifungal drug resistance in fungi. Maurizio Sanguinetti
14.00 Molecular basis of azole resistance in Candida and Aspergillus species. Manuel Cuenca-Estrella
14.20 Is there a need for drug monitoring of antifungals? Andreas H. Groll
14.40 The role of heat-shock proteins in fungal infection. James Burnie
15.00 Discussion
15.20 Coffee break
4. Immunopathogenesis and adjunctive therapies
15.40 Defining an invasive fungal infection for different settings: research vs practice. J. Peter Donnelly
16.00 Targeted immune suppressive therapies and emerging fungal infections. Winfried V. Kern
16.20 Air and the risk of invasive pulmonary aspergillosis. Emilio Bouza
16.40 Solid organ transplantation. Patricia Muñoz
17.00 Host immune response to fungal infections. Emmanuel Roilides
17.20 Discussion
Friday, 19 February 2010
5. Risk assessment and therapeutic choices
9.00 Risk assessment for the invasive fungal infections in the ICU. Murat Akova
9.20 Treatment of Candida sepsis in the ICU. Thierry Calandra
9.40 Cryptococcosis: an example for fungal immune reconstitution syndrome. Olivier Lortholary
10.00 Does treatment differ in children? Theoklis Zaoutis
10.20 Discussion
10.40 Coffee break
6. Strategies in treatment and prophylaxis of invasive fungal infections
11.00 Infection control and prevention of mould infections. Georg Maschmeyer
11.20 Prophylaxis versus treatment. Andrew Ullmann
11.40 Empirical therapy and pre-emptive approach. Johan Maertens
12.00 Combination antifungal therapy: everybody knows that it works, but where are the data? Claudio Viscoli
12.20 Discussion
12:45 End of conference
Confirmed Conference Faculty
- Murat Akova, Ankara, TR
- Sevtap Arikan, Ankara, TR
- Emilio Bouza, Madrid, ES
- Stéphane Bretagne, Crétail, FR
- James Burnie, Manchester, UK
- Thierry Calandra, Lausanne, CH
- Manuel Cuenca-Estrella, Majadahonda, ES
- J. Peter Donnelly, Nijmegen, NL
- Andreas H. Groll, Münster, DE
- Claus Peter Heussel, Heidelberg, DE
- Elizabeth M. Johnson, Bristol, UK
- Winfried V. Kern, Freiburg, DE
- Cornelia Lass-Flörl, Innsbruck, AT
- Olivier Lortholary, Paris, FR
- Johan Maertens, Leuven, BE
- Georg Maschmeyer, Potsdam, DE
- Patricia Muñoz, Madrid, ES
- Marcio Nucci, Rio de Janeiro, BR
- George Petrikkos, Athens, GR
- Emmanuel Roilides, Thessaloniki, GR
- Maurizio Sanguinetti, Rome, IT
- Andrew Ullmann, Mainz, DE
- Paul Verweij, Nijmegen, NL
- Claudio Viscoli, Genoa, IT
- Theoklis Zaoutis, Philadelphia, US
